RS

Rob Steendam

Chief Technology Officer

InnoCore Pharmaceuticals

Groningen, Groningen


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
InnoCore Pharmaceuticals
Industry
pharmaceuticals
Employees
45.0
Seniority
C suite
Annual Revenue
7300000.0

Technologies

Outlook Microsoft Office 365 reCAPTCHA Mobile Friendly Google Maps Google Tag Manager Google Maps (Non Paid Users) Google Analytics Ecommerce Tracking Apache Remote

Keywords

solid implants injectable microspheres insitu forming implants synbiosys polymers long acting injectables low solubles drug eluting stent coatings plga hydrogel pharmaceutical manufacturing drug delivery biodegradable polymers injectable formulations sustained release controlled release systems pharmaceutical development formulation services preclinical development clinical phase support partnering solutions polymer technologies microsphere technology nano-particle drug delivery gel formulations implant technology drug formulation patient compliance biologics delivery peptide delivery protein therapeutics small molecule delivery sustained release technologies ingell technology synbiosys platform high-throughput testing microencapsulation drug stability bioactivity preservation glp compliance gmp manufacturing biocompatibility dosage forms pharmaceutical r&d toxicity mitigation innovative treatments injectable gels liquid polymer delivery pharma injectables collaborative partnerships customer-focused approach drug development solutions therapeutic areas pancreatic islets delivery microneedles technology contract development services analytical development high-quality solutions pharmaceuticals medical

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans